The treatment of acute malaria with single oral doses of amodiaquin, chloroquine, hydroxychloroquine and pyrimethamine

Am J Trop Med Hyg. 1954 Sep;3(5):833-8. doi: 10.4269/ajtmh.1954.3.833.

M T HOEKENGA

PMID: 13197717 DOI: 10.4269/ajtmh.1954.3.833

Products

Cat. No.

Product Name

Description

Target

Research Area
HY-B1322

Amodiaquine dihydrochloride dihydrate

99.89%, Antimalarial Agent

Nuclear Hormone Receptor 4A/NR4A; Parasite; Histone Methyltransferase

Neurological Disease; Inflammation/Immunology; Infection
HY-B1322A

Amodiaquine

99.98%, Antimalarial Agent

Nuclear Hormone Receptor 4A/NR4A; Parasite; Histone Methyltransferase

Neurological Disease; Inflammation/Immunology; Infection
HY-B1322AS

Amodiaquine-d₁₀

Stable Isotope

Parasite; Histone Methyltransferase

Neurological Disease; Inflammation/Immunology; Infection

MedChemExpress Magic Cece

MedChemExpress: Contact Us; About Us; Headquarters; Distributors; Statement on False Report; Careers

Customer Support: Technical Support; Service; Ordering Information; Easy Return; Shipping Rates & Policies; Intellectual Property Promise

Resources: Free Sample; Resources; Molarity Calculator; Dilution Calculator; Terms & Conditions; Reconstitution Calculator; Specific Activity Calculator

Subscribe to our E-newsletter

Products are chemical reagents for research use only and are not intended for human use. We do not sell to patients.

Copyright © 2013-2024 MedChemExpress. All Rights Reserved.: Site Map Privacy Policy

Join with us